William Heiden, President & CEO, Director at Amag Pharmaceuticals, holds 20.50K shares in Atara Biotherapeutics (Ticker: ATRA), holds 424.61K shares in Amag Pharmaceuticals (Ticker: AMAG).

See the Hottest Stocks Based on Insider Trading >

William Heiden
Amag Pharmaceuticals (AMAG)
President & CEO, Director

Ranked #49,776 out of 78,624 Corporate Insiders

Profitable Transactions

1 out of 3 Profitable Transactions

Average Return

-10.70%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ATRA

A breakdown of William Heiden's holdings

See the Top Stocks by Insiders

Insider Roles

Atara Biotherapeutics
(ATRA)

Director

Roles that William Heiden holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Amag Pharmaceuticals
(AMAG)

Rating:Informative Buy

Date:May 17, 2016 - May 17, 2017

Return:+5.30%

The most profitable trade made by William Heiden

See the Latest Stocks Traded by Insiders

William Heiden's Trading History

AMAG

Amag Pharmaceuticals

Mar 04, 2020

―

Uninformative Sell

34.50K

$5.84M

ATRA

Atara Biotherapeutics

Jun 17, 2020

Director

Uninformative Buy

―

$477.04K

List of latest transactions for each holding click on a transaction to see William Heiden's performance on stock

See All Insider Trading from Today

William Heiden insider profile FAQ

What is the percentage of profitable transactions made by William Heiden?

The percentage of profitable transactions made by William Heiden is 33%.

What is the average return per transaction made by William Heiden?

The average return per transaction made by William Heiden is -10.70%.

What stocks does William Heiden hold?

William Heiden holds: AMAG, ATRA stocks.

What was William Heiden’s latest transaction?

William Heiden latest transaction was an Uninformative Buy of ―.

What was William Heiden's most profitable transaction?

William Heiden’s most profitable transaction was an Informative Buy of AMAG stock on May 17, 2016. The return on the trade was 5.30%.

What is William Heiden's role in Amag Pharmaceuticals?

William Heiden's role in Amag Pharmaceuticals is President & CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

William Heiden Insider Profile

William Heiden Amag Pharmaceuticals (AMAG)President & CEO, Director